<code id='B591EABB87'></code><style id='B591EABB87'></style>
    • <acronym id='B591EABB87'></acronym>
      <center id='B591EABB87'><center id='B591EABB87'><tfoot id='B591EABB87'></tfoot></center><abbr id='B591EABB87'><dir id='B591EABB87'><tfoot id='B591EABB87'></tfoot><noframes id='B591EABB87'>

    • <optgroup id='B591EABB87'><strike id='B591EABB87'><sup id='B591EABB87'></sup></strike><code id='B591EABB87'></code></optgroup>
        1. <b id='B591EABB87'><label id='B591EABB87'><select id='B591EABB87'><dt id='B591EABB87'><span id='B591EABB87'></span></dt></select></label></b><u id='B591EABB87'></u>
          <i id='B591EABB87'><strike id='B591EABB87'><tt id='B591EABB87'><pre id='B591EABB87'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:325
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Unique patient identifier: Experts argue the benefits, pitfalls
          Unique patient identifier: Experts argue the benefits, pitfalls

          Therehasbeenlong-standingdebateintheUSoverwhethertoimplementauniquepatientidentifiersystem.EvanVucci

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Global cancer cases to surge 77% by 2050, WHO report says

          MassGeneralCancerCenterThepredictionisdire:Cancercasesaroundtheworldareexpectedtosurge77%by2050,anew